1	Involvement	Involvement	B-NP	NN	O	0	ROOT	0
2	of	of	B-PP	IN	O	1	NMOD	-1
3	PTEN	PTEN	B-NP	NN	O	5	NMOD	-1
4	promoter	promoter	I-NP	NN	O	5	NMOD	-1
5	methylation	methylation	I-NP	NN	O	2	PMOD	0
6	in	in	B-PP	IN	O	1	NMOD	-1
7	cerebral	cerebral	B-NP	JJ	O	9	NMOD	-1
8	cavernous	cavernous	I-NP	JJ	O	9	NMOD	-1
9	malformations	malformation	I-NP	NNS	O	6	PMOD	-1
10	.	.	O	.	O	1	P	-1

1	BACKGROUND	BACKGROUND	B-NP	NN	O	3	NMOD	-1
2	AND	AND	I-NP	CC	O	3	NMOD	-1
3	PURPOSE	PURPOSE	I-NP	NN	O	0	ROOT	-1
4	:	:	O	:	O	3	P	-1
5	Cerebral	Cerebral	B-NP	JJ	O	7	NMOD	-1
6	cavernous	cavernous	I-NP	JJ	O	7	NMOD	-1
7	malformations	malformation	I-NP	NNS	O	11	SUB	-1
8	(	(	O	(	O	10	DEP	-1
9	CCMs	CCM	B-NP	NNS	O	10	DEP	-1
10	)	)	O	)	O	7	NMOD	-1
11	are	be	B-VP	VBP	O	3	NMOD	-1
12	prevalent	prevalent	B-NP	JJ	O	15	NMOD	-1
13	cerebral	cerebral	I-NP	JJ	O	15	NMOD	-1
14	vascular	vascular	I-NP	JJ	O	15	NMOD	-1
15	lesions	lesion	I-NP	NNS	O	11	PRD	-1
16	involving	involve	B-VP	VBG	O	15	NMOD	0
17	aberrant	aberrant	B-NP	JJ	O	18	NMOD	0
18	angiogenesis	angiogenesis	I-NP	NN	O	16	OBJ	3	angiogenesis
19	.	.	O	.	O	11	P	-1

1	However	However	B-ADVP	RB	O	6	VMOD	-1
2	,	,	O	,	O	6	P	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	underlying	underlying	I-NP	JJ	O	5	NMOD	-1
5	mechanism	mechanism	I-NP	NN	O	6	SUB	0
6	is	be	B-VP	VBZ	O	0	ROOT	-1
7	poorly	poorly	B-ADJP	RB	O	6	VMOD	-1
8	understood	understand	I-ADJP	VBN	O	6	VC	-1
9	.	.	O	.	O	6	P	-1

1	Phosphatase	Phosphatase	B-NP	NN	B-protein	4	NMOD	-1
2	and	and	I-NP	CC	O	4	NMOD	-1
3	tension	tension	I-NP	NN	O	4	NMOD	-1
4	homolog	homolog	I-NP	NN	O	17	SUB	-1
5	deleted	delete	B-VP	VBN	O	4	NMOD	-1
6	on	on	B-PP	IN	O	5	VMOD	-1
7	chromosome	chromosome	B-NP	NN	B-DNA	15	NMOD	-1
8	10	10	I-NP	CD	I-DNA	7	NMOD	-1
9	(	(	O	(	O	11	DEP	-1
10	PTEN	PTEN	B-NP	NN	B-protein	11	DEP	-1
11	)	)	O	)	O	7	NMOD	-1
12	,	,	O	,	O	15	P	-1
13	a	a	B-NP	DT	O	15	NMOD	-1
14	tumor	tumor	I-NP	NN	B-protein	15	NMOD	-1
15	suppressor	suppressor	I-NP	NN	I-protein	6	PMOD	0
16	,	,	O	,	O	4	P	-1
17	is	be	B-VP	VBZ	O	0	ROOT	-1
18	frequently	frequently	B-ADJP	RB	O	19	AMOD	-1
19	deficient	deficient	I-ADJP	JJ	O	17	PRD	9	deficient
20	in	in	B-PP	IN	O	19	AMOD	-1
21	various	various	B-NP	JJ	O	22	NMOD	-1
22	pathologies	pathology	I-NP	NNS	O	20	PMOD	-1
23	due	due	B-ADJP	JJ	O	19	AMOD	0
24	to	to	B-PP	TO	O	23	AMOD	-1
25	mutation	mutation	B-NP	NN	O	28	NMOD	-1
26	or	or	I-NP	CC	O	28	NMOD	-1
27	epigenetic	epigenetic	I-NP	JJ	O	28	NMOD	-1
28	alterations	alteration	I-NP	NNS	O	24	PMOD	0
29	.	.	O	.	O	17	P	-1

1	PTEN	PTEN	B-NP	NN	O	3	NMOD	-1
2	promoter	promoter	I-NP	NN	O	3	NMOD	-1
3	hypermethylation	hypermethylation	I-NP	NN	O	4	SUB	0
4	is	be	B-VP	VBZ	O	0	ROOT	-1
5	a	a	B-NP	DT	O	9	NMOD	-1
6	major	major	I-NP	JJ	O	9	NMOD	-1
7	epigenetic	epigenetic	I-NP	JJ	O	9	NMOD	-1
8	silencing	silencing	I-NP	NN	O	9	NMOD	-1
9	mechanism	mechanism	I-NP	NN	O	4	PRD	0
10	leading	lead	B-VP	VBG	O	9	NMOD	17	leading
11	to	to	B-PP	TO	O	10	VMOD	-1
12	activation	activation	B-NP	NN	O	11	PMOD	17	activation
13	of	of	B-PP	IN	O	12	NMOD	-1
14	angiogenesis	angiogenesis	B-NP	NN	O	13	PMOD	3	angiogenesis
15	in	in	B-PP	IN	O	12	NMOD	-1
16	tumors	tumor	B-NP	NNS	O	15	PMOD	-1
17	.	.	O	.	O	4	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	present	present	I-NP	JJ	O	3	NMOD	0
3	study	study	I-NP	NN	O	4	SUB	-1
4	aimed	aim	B-VP	VBD	O	0	ROOT	-1
5	to	to	I-VP	TO	O	6	VMOD	-1
6	investigate	investigate	I-VP	VB	O	4	VMOD	-1
7	whether	whether	B-SBAR	IN	O	6	VMOD	-1
8	PTEN	PTEN	B-NP	NN	O	10	NMOD	-1
9	promoter	promoter	I-NP	NN	O	10	NMOD	-1
10	methylation	methylation	I-NP	NN	O	11	SUB	0
11	was	be	B-VP	VBD	O	7	SBAR	-1
12	involved	involve	I-VP	VBN	O	11	VC	0
13	in	in	B-PP	IN	O	12	VMOD	-1
14	CCMs	CCM	B-NP	NNS	B-cell_type	13	PMOD	-1
15	.	.	O	.	O	4	P	-1

1	METHODS	METHODS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	PTEN	PTEN	B-NP	NN	O	5	NMOD	-1
4	promoter	promoter	I-NP	NN	O	5	NMOD	-1
5	methylation	methylation	I-NP	NN	O	6	SUB	0
6	was	be	B-VP	VBD	O	1	NMOD	-1
7	detected	detect	I-VP	VBN	O	6	VC	0
8	in	in	B-PP	IN	O	7	VMOD	-1
9	surgical	surgical	B-NP	JJ	O	10	NMOD	-1
10	specimens	specimen	I-NP	NNS	O	8	PMOD	-1
11	of	of	B-PP	IN	O	10	NMOD	-1
12	CCMs	CCM	B-NP	NNS	O	11	PMOD	-1
13	(	(	O	(	O	15	DEP	-1
14	n=69	n=69	B-NP	NN	O	15	DEP	-1
15	)	)	O	)	O	12	NMOD	-1
16	by	by	B-PP	IN	O	7	VMOD	-1
17	methylation-specific	methylation-specific	B-NP	JJ	O	20	NMOD	-1
18	polymerase	polymerase	I-NP	NN	O	20	NMOD	-1
19	chain	chain	I-NP	NN	O	20	NMOD	-1
20	reaction	reaction	I-NP	NN	O	16	PMOD	-1
21	.	.	O	.	O	1	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	methylation	methylation	I-NP	NN	O	3	NMOD	0
3	status	status	I-NP	NN	O	4	SUB	-1
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	correlated	correlate	I-VP	VBN	O	4	VC	-1
6	to	to	B-PP	TO	O	5	VMOD	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	clinical	clinical	I-NP	JJ	O	9	NMOD	-1
9	manifestations	manifestation	I-NP	NNS	O	6	PMOD	-1
10	and	and	B-PP	CC	O	6	PMOD	-1
11	to	to	B-PP	TO	O	6	PMOD	-1
12	PTEN	PTEN	B-NP	NN	B-protein	13	NMOD	-1
13	expression	expression	I-NP	NN	O	11	PMOD	9	expression
14	,	,	O	,	O	13	P	-1
15	which	which	B-NP	WDT	O	13	NMOD	-1
16	was	be	B-VP	VBD	O	15	SBAR	-1
17	analyzed	analyze	I-VP	VBN	O	16	VC	-1
18	by	by	B-PP	IN	O	17	VMOD	-1
19	both	both	B-NP	CC	O	23	NMOD	-1
20	Western	Western	I-NP	JJ	O	21	NMOD	-1
21	blot	blot	I-NP	NN	O	23	NMOD	-1
22	and	and	I-NP	CC	O	23	NMOD	-1
23	immunohistochemistry	immunohistochemistry	I-NP	NN	O	18	PMOD	-1
24	.	.	O	.	O	4	P	-1

1	To	To	B-VP	TO	O	2	VMOD	-1
2	investigate	investigate	I-VP	VB	O	28	VMOD	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	endothelial	endothelial	I-NP	JJ	O	5	NMOD	-1
5	proliferation	proliferation	I-NP	NN	O	10	NMOD	1	proliferation
6	and	and	O	CC	O	10	NMOD	-1
7	the	the	B-NP	DT	O	10	NMOD	-1
8	potential	potential	I-NP	JJ	O	10	NMOD	0
9	signaling	signaling	I-NP	NN	O	10	NMOD	0
10	pathways	pathway	I-NP	NNS	O	2	OBJ	0
11	affected	affect	B-VP	VBN	O	10	NMOD	16	affected
12	by	by	B-PP	IN	O	11	VMOD	-1
13	PTEN	PTEN	B-NP	NN	O	14	NMOD	-1
14	methylation	methylation	I-NP	NN	O	12	PMOD	0
15	,	,	O	,	O	2	P	-1
16	proliferating	proliferate	B-VP	VBG	O	2	VMOD	0
17	cell	cell	B-NP	NN	O	19	NMOD	-1
18	nuclear	nuclear	I-NP	JJ	O	19	NMOD	-1
19	antigen	antigen	I-NP	NN	O	25	NMOD	-1
20	as	as	B-CONJP	RB	O	25	NMOD	-1
21	well	well	I-CONJP	RB	O	20	DEP	-1
22	as	as	I-CONJP	IN	O	20	DEP	-1
23	phosphor-Akt	phosphor-Akt	B-NP	NN	O	25	NMOD	-1
24	and	and	I-NP	CC	O	25	NMOD	-1
25	phosphor-Erk1	phosphor-Erk1	I-NP	NN	O	16	OBJ	-1
26	,	,	O	,	O	28	P	-1
27	2	2	B-NP	CD	O	28	SUB	-1
28	were	be	B-VP	VBD	O	0	ROOT	-1
29	detected	detect	I-VP	VBN	O	28	VC	0
30	by	by	B-PP	IN	O	29	VMOD	-1
31	immunofluorescence	immunofluorescence	B-NP	NN	O	34	NMOD	-1
32	and	and	I-NP	CC	O	34	NMOD	-1
33	Western	Western	I-NP	NN	O	34	NMOD	-1
34	blot	blot	I-NP	NN	O	30	PMOD	-1
35	,	,	O	,	O	29	P	-1
36	respectively	respectively	B-ADVP	RB	O	29	VMOD	-1
37	,	,	O	,	O	29	P	-1
38	in	in	B-PP	IN	O	29	VMOD	-1
39	CCM	CCM	B-NP	NN	O	40	NMOD	-1
40	specimens	specimen	I-NP	NNS	O	38	PMOD	-1
41	.	.	O	.	O	28	P	-1

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	-1
3	Methylation-specific	Methylation-specific	B-NP	JJ	O	6	NMOD	-1
4	polymerase	polymerase	I-NP	NN	O	6	NMOD	-1
5	chain	chain	I-NP	NN	O	6	NMOD	-1
6	reaction	reaction	I-NP	NN	O	7	SUB	-1
7	revealed	reveal	B-VP	VBD	O	1	NMOD	-1
8	PTEN	PTEN	B-NP	NN	O	10	NMOD	-1
9	promoter	promoter	I-NP	NN	O	10	NMOD	-1
10	methylation	methylation	I-NP	NN	O	7	OBJ	0
11	in	in	B-PP	IN	O	10	NMOD	-1
12	15.9	15.9	B-NP	CD	O	14	NMOD	-1
13	%	%	I-NP	NN	O	14	NMOD	-1
14	CCMs	CCM	I-NP	NNS	O	11	PMOD	-1
15	.	.	O	.	O	1	P	-1

1	Strikingly	Strikingly	B-ADVP	RB	O	8	VMOD	-1
2	,	,	O	,	O	8	P	-1
3	5	5	B-NP	CD	O	4	AMOD	-1
4	of	of	B-PP	IN	O	8	VMOD	-1
5	6	6	B-NP	CD	O	4	AMOD	-1
6	familial	familial	I-NP	JJ	O	7	NMOD	-1
7	CCMs	CCM	I-NP	NNS	O	8	SUB	-1
8	showed	show	B-VP	VBD	O	0	ROOT	-1
9	PTEN	PTEN	B-NP	NN	O	11	NMOD	-1
10	promoter	promoter	I-NP	NN	O	11	NMOD	-1
11	methylation	methylation	I-NP	NN	O	8	OBJ	0
12	(	(	O	(	O	15	DEP	-1
13	83.3	83.3	B-NP	CD	O	14	NMOD	-1
14	%	%	I-NP	NN	O	15	DEP	-1
15	)	)	O	)	O	11	NMOD	-1
16	,	,	O	,	O	11	P	-1
17	which	which	B-NP	WDT	O	11	NMOD	-1
18	was	be	B-VP	VBD	O	17	SBAR	-1
19	significantly	significantly	B-ADJP	RB	O	20	AMOD	-1
20	higher	high	I-ADJP	JJR	O	18	PRD	-1
21	than	than	B-PP	IN	O	20	AMOD	-1
22	in	in	B-PP	IN	O	21	PMOD	-1
23	sporadic	sporadic	B-NP	JJ	O	24	NMOD	-1
24	cases	case	I-NP	NNS	O	22	PMOD	-1
25	(	(	O	(	O	32	DEP	-1
26	9.4	9.4	B-NP	CD	O	27	NMOD	-1
27	%	%	I-NP	NN	O	31	VMOD	-1
28	;	;	O	:	O	31	P	-1
29	P	P	B-NP	NN	O	31	SUB	-1
30	<	<	B-NP	SYM	O	31	VMOD	-1
31	0.001	0.001	I-NP	CD	O	32	DEP	-1
32	)	)	O	)	O	20	AMOD	-1
33	.	.	O	.	O	8	P	-1

1	In	In	B-PP	IN	O	7	VMOD	-1
2	addition	addition	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	7	P	-1
4	PTEN	PTEN	B-NP	NN	O	6	NMOD	-1
5	promoter	promoter	I-NP	NN	O	6	NMOD	-1
6	methylation	methylation	I-NP	NN	O	7	SUB	0
7	appeared	appear	B-VP	VBD	O	0	ROOT	-1
8	more	more	B-ADVP	RBR	O	9	AMOD	-1
9	frequently	frequently	I-ADVP	RB	O	7	PRD	-1
10	in	in	B-PP	IN	O	9	AMOD	-1
11	multiple	multiple	B-NP	JJ	O	12	NMOD	-1
12	CCMs	CCM	I-NP	NNS	O	10	PMOD	-1
13	,	,	O	,	O	12	P	-1
14	including	include	B-PP	VBG	O	12	NMOD	-1
15	familial	familial	B-NP	JJ	O	16	NMOD	-1
16	cases	case	I-NP	NNS	O	14	PMOD	-1
17	(	(	O	(	O	20	DEP	-1
18	46.7	46.7	B-NP	CD	O	19	NMOD	-1
19	%	%	I-NP	NN	O	20	DEP	-1
20	)	)	O	)	O	16	NMOD	-1
21	,	,	O	,	O	9	P	-1
22	than	than	B-PP	IN	O	9	AMOD	-1
23	that	that	B-NP	DT	O	22	PMOD	-1
24	in	in	B-PP	IN	O	23	NMOD	-1
25	single-lesioned	single-lesioned	B-NP	JJ	O	26	NMOD	-1
26	CCMs	CCM	I-NP	NNS	O	24	PMOD	-1
27	(	(	O	(	O	34	DEP	-1
28	11.8	11.8	B-NP	CD	O	29	NMOD	-1
29	%	%	I-NP	NN	O	34	DEP	-1
30	;	;	O	:	O	34	P	-1
31	P	P	B-NP	NN	O	34	DEP	-1
32	<	<	B-NP	SYM	O	31	NMOD	-1
33	0.05	0.05	I-NP	CD	O	32	AMOD	-1
34	)	)	O	)	O	23	NMOD	-1
35	.	.	O	.	O	7	P	-1

1	Immunostaining	Immunostaining	B-NP	NN	O	4	NMOD	-1
2	and	and	I-NP	CC	O	4	NMOD	-1
3	Western	Western	I-NP	NN	O	4	NMOD	-1
4	blot	blot	I-NP	NN	O	5	SUB	-1
5	revealed	reveal	B-VP	VBD	O	0	ROOT	-1
6	a	a	B-NP	DT	O	10	NMOD	-1
7	more	more	I-NP	RBR	O	8	AMOD	-1
8	significant	significant	I-NP	JJ	O	10	NMOD	-1
9	PTEN	PTEN	I-NP	NN	O	10	NMOD	-1
10	downregulation	downregulation	I-NP	NN	O	5	OBJ	18	downregulation
11	in	in	B-PP	IN	O	10	NMOD	-1
12	PTEN-methylated	PTEN-methylated	B-NP	JJ	O	13	NMOD	-1
13	CCMs	CCM	I-NP	NNS	O	11	PMOD	-1
14	in	in	B-PP	IN	O	10	NMOD	-1
15	comparison	comparison	B-NP	NN	O	14	PMOD	-1
16	to	to	B-PP	TO	O	15	NMOD	-1
17	PTEN-unmethylated	PTEN-unmethylated	B-NP	JJ	O	18	NMOD	-1
18	CCMs	CCM	I-NP	NNS	O	16	PMOD	-1
19	.	.	O	.	O	5	P	-1

1	Reduced	Reduce	B-NP	VBN	O	3	NMOD	18	Reduced
2	PTEN	PTEN	I-NP	NN	B-protein	3	NMOD	-1
3	expression	expression	I-NP	NN	O	4	SUB	9	expression
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	inversely	inversely	I-VP	RB	O	4	VMOD	-1
6	correlated	correlate	I-VP	VBN	O	4	VC	-1
7	to	to	B-PP	TO	O	6	VMOD	-1
8	the	the	B-NP	DT	O	9	NMOD	-1
9	expression	expression	I-NP	NN	O	7	PMOD	9	expression
10	of	of	B-PP	IN	O	9	NMOD	-1
11	proliferating	proliferate	B-VP	VBG	O	10	PMOD	0
12	cell	cell	B-NP	NN	O	14	NMOD	-1
13	nuclear	nuclear	I-NP	JJ	O	14	NMOD	-1
14	antigen	antigen	I-NP	NN	O	11	OBJ	-1
15	and	and	B-PP	CC	O	7	PMOD	-1
16	to	to	B-PP	TO	O	7	PMOD	-1
17	the	the	B-NP	DT	O	18	NMOD	-1
18	activation	activation	I-NP	NN	O	16	PMOD	17	activation
19	of	of	B-PP	IN	O	18	NMOD	-1
20	Erk1	Erk1	B-NP	NN	B-protein	19	PMOD	-1
21	,	,	O	,	O	22	P	-1
22	2	2	B-NP	CD	O	20	NMOD	-1
23	,	,	O	,	O	22	NMOD	-1
24	but	but	O	CC	O	23	ROOT	-1
25	not	not	B-PP	RB	O	26	PMOD	-1
26	of	of	I-PP	IN	O	24	PRD	-1
27	Akt	Akt	B-NP	NN	B-protein	26	PMOD	-1
28	.	.	O	.	O	24	P	-1

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	We	We	B-NP	PRP	O	4	SUB	-1
4	reported	report	B-VP	VBD	O	1	NMOD	-1
5	here	here	B-ADVP	RB	O	4	VMOD	-1
6	for	for	B-PP	IN	O	4	VMOD	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	first	first	I-NP	JJ	O	9	NMOD	-1
9	time	time	I-NP	NN	O	6	PMOD	-1
10	the	the	B-NP	DT	O	11	NMOD	-1
11	involvement	involvement	I-NP	NN	O	4	VMOD	0
12	of	of	B-PP	IN	O	11	NMOD	-1
13	PTEN	PTEN	B-NP	NN	O	15	NMOD	-1
14	promoter	promoter	I-NP	NN	O	15	NMOD	-1
15	methylation	methylation	I-NP	NN	O	12	PMOD	0
16	in	in	B-PP	IN	O	11	NMOD	-1
17	CCMs	CCM	B-NP	NNS	O	16	PMOD	-1
18	,	,	O	,	O	11	P	-1
19	particularly	particularly	B-ADVP	RB	O	20	PMOD	-1
20	in	in	B-PP	IN	O	11	NMOD	-1
21	familial	familial	B-NP	JJ	O	22	NMOD	-1
22	CCMs	CCM	I-NP	NNS	O	20	PMOD	-1
23	,	,	O	,	O	11	P	-1
24	suggesting	suggest	B-VP	VBG	O	11	NMOD	-1
25	this	this	B-NP	DT	O	27	NMOD	-1
26	epigenetic	epigenetic	I-NP	JJ	O	27	NMOD	-1
27	alteration	alteration	I-NP	NN	O	24	OBJ	-1
28	as	as	B-PP	IN	O	24	VMOD	-1
29	a	a	B-NP	DT	O	31	NMOD	-1
30	potential	potential	I-NP	JJ	O	31	NMOD	0
31	pathomechanism	pathomechanism	I-NP	NN	O	28	PMOD	-1
32	of	of	B-PP	IN	O	31	NMOD	-1
33	CCMs	CCM	B-NP	NNS	B-protein	32	PMOD	-1
34	.	.	O	.	O	1	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	identification	identification	I-NP	NN	O	13	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	Erk1	Erk1	B-NP	NN	B-protein	6	NMOD	-1
5	,	,	O	,	O	6	P	-1
6	2	2	B-NP	CD	O	3	PMOD	-1
7	as	as	B-PP	IN	O	6	NMOD	-1
8	triggered	triggered	B-NP	JJ	O	9	NMOD	0
9	signaling	signaling	I-NP	NN	O	7	PMOD	0
10	in	in	B-PP	IN	O	9	NMOD	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	lesions	lesion	I-NP	NNS	O	10	PMOD	-1
13	may	may	B-VP	MD	O	0	ROOT	-1
14	be	be	I-VP	VB	O	13	VC	-1
15	valuable	valuable	B-ADJP	JJ	O	14	PRD	-1
16	for	for	B-PP	IN	O	15	AMOD	-1
17	the	the	B-NP	DT	O	18	NMOD	-1
18	development	development	I-NP	NN	O	16	PMOD	0
19	of	of	B-PP	IN	O	18	NMOD	-1
20	effective	effective	B-NP	JJ	O	21	NMOD	0
21	therapy	therapy	I-NP	NN	O	19	PMOD	0
22	for	for	B-PP	IN	O	18	NMOD	-1
23	this	this	B-NP	DT	O	24	NMOD	-1
24	disease	disease	I-NP	NN	O	22	PMOD	-1
25	.	.	O	.	O	13	P	-1

